| Jessica L Macleod, APRN | |
|
142 Woodridge Drive, Berlin, VT 05602-9516 | |
| (802) 371-4700 | |
| (802) 371-4720 |
| Full Name | Jessica L Macleod |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 15 Years |
| Location | 142 Woodridge Drive, Berlin, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336469337 | NPI | - | NPPES |
| 1017871 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | 101-0068303 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Caledonia Home Health Care | Saint johnsbury, VT | Home health agency |
| Northeastern Vermont Regional Hospital | Saint johnsbury, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeastern Vermont Regional Hospital Inc | 3678481405 | 102 |
News Archive
Great Lakes NeuroTechnologies announced today they will be using a $1.5M award from NIH to expand their Parkinson's monitoring technology to mobile applications. Repositioning GLNT's Kinesia product line with mobile apps strategically aligns with growing trends in domestic and international healthcare landscapes regarding accessibility, costs, reimbursement, and regulatory policies.
A recent study found that living donation increased 42% and the number of individuals who presented for donation evaluation increased 74% at centers in New York. The surge in live donation and donor evaluation occurred after additional education was provided to liver transplant candidates.
Advanced Medical Isotope Corporation ("AMIC"), a company engaged in the development, production and distribution of medical isotopes focused on yttrium-90 brachytherapy devices, today announced that it has received a response from the FDA to its pre-market notification to the FDA pursuant to Section 510(k) of the U.S. Food, Drug and Cosmetic Act for its Yttrium-90 (Y-90) RadioGel(tm) patented brachytherapy cancer product.
The U.S. Army Medical Research and Development Command announced today that the U.S. Food and Drug Administration granted marketing approval for Artesunate for Injection, an initial treatment for severe malaria.
› Verified 7 days ago
| Entity Name | Central Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831374362 PECOS PAC ID: 9335138817 Enrollment ID: O20040510001034 |
News Archive
Great Lakes NeuroTechnologies announced today they will be using a $1.5M award from NIH to expand their Parkinson's monitoring technology to mobile applications. Repositioning GLNT's Kinesia product line with mobile apps strategically aligns with growing trends in domestic and international healthcare landscapes regarding accessibility, costs, reimbursement, and regulatory policies.
A recent study found that living donation increased 42% and the number of individuals who presented for donation evaluation increased 74% at centers in New York. The surge in live donation and donor evaluation occurred after additional education was provided to liver transplant candidates.
Advanced Medical Isotope Corporation ("AMIC"), a company engaged in the development, production and distribution of medical isotopes focused on yttrium-90 brachytherapy devices, today announced that it has received a response from the FDA to its pre-market notification to the FDA pursuant to Section 510(k) of the U.S. Food, Drug and Cosmetic Act for its Yttrium-90 (Y-90) RadioGel(tm) patented brachytherapy cancer product.
The U.S. Army Medical Research and Development Command announced today that the U.S. Food and Drug Administration granted marketing approval for Artesunate for Injection, an initial treatment for severe malaria.
› Verified 7 days ago
| Entity Name | Central Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023028784 PECOS PAC ID: 9335138817 Enrollment ID: O20051220000393 |
News Archive
Great Lakes NeuroTechnologies announced today they will be using a $1.5M award from NIH to expand their Parkinson's monitoring technology to mobile applications. Repositioning GLNT's Kinesia product line with mobile apps strategically aligns with growing trends in domestic and international healthcare landscapes regarding accessibility, costs, reimbursement, and regulatory policies.
A recent study found that living donation increased 42% and the number of individuals who presented for donation evaluation increased 74% at centers in New York. The surge in live donation and donor evaluation occurred after additional education was provided to liver transplant candidates.
Advanced Medical Isotope Corporation ("AMIC"), a company engaged in the development, production and distribution of medical isotopes focused on yttrium-90 brachytherapy devices, today announced that it has received a response from the FDA to its pre-market notification to the FDA pursuant to Section 510(k) of the U.S. Food, Drug and Cosmetic Act for its Yttrium-90 (Y-90) RadioGel(tm) patented brachytherapy cancer product.
The U.S. Army Medical Research and Development Command announced today that the U.S. Food and Drug Administration granted marketing approval for Artesunate for Injection, an initial treatment for severe malaria.
› Verified 7 days ago
| Entity Name | Northeastern Vermont Regional Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659459428 PECOS PAC ID: 3678481405 Enrollment ID: O20080208000261 |
News Archive
Great Lakes NeuroTechnologies announced today they will be using a $1.5M award from NIH to expand their Parkinson's monitoring technology to mobile applications. Repositioning GLNT's Kinesia product line with mobile apps strategically aligns with growing trends in domestic and international healthcare landscapes regarding accessibility, costs, reimbursement, and regulatory policies.
A recent study found that living donation increased 42% and the number of individuals who presented for donation evaluation increased 74% at centers in New York. The surge in live donation and donor evaluation occurred after additional education was provided to liver transplant candidates.
Advanced Medical Isotope Corporation ("AMIC"), a company engaged in the development, production and distribution of medical isotopes focused on yttrium-90 brachytherapy devices, today announced that it has received a response from the FDA to its pre-market notification to the FDA pursuant to Section 510(k) of the U.S. Food, Drug and Cosmetic Act for its Yttrium-90 (Y-90) RadioGel(tm) patented brachytherapy cancer product.
The U.S. Army Medical Research and Development Command announced today that the U.S. Food and Drug Administration granted marketing approval for Artesunate for Injection, an initial treatment for severe malaria.
› Verified 7 days ago
| Entity Name | Northeastern Vermont Regional Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871870899 PECOS PAC ID: 3678481405 Enrollment ID: O20120306000545 |
News Archive
Great Lakes NeuroTechnologies announced today they will be using a $1.5M award from NIH to expand their Parkinson's monitoring technology to mobile applications. Repositioning GLNT's Kinesia product line with mobile apps strategically aligns with growing trends in domestic and international healthcare landscapes regarding accessibility, costs, reimbursement, and regulatory policies.
A recent study found that living donation increased 42% and the number of individuals who presented for donation evaluation increased 74% at centers in New York. The surge in live donation and donor evaluation occurred after additional education was provided to liver transplant candidates.
Advanced Medical Isotope Corporation ("AMIC"), a company engaged in the development, production and distribution of medical isotopes focused on yttrium-90 brachytherapy devices, today announced that it has received a response from the FDA to its pre-market notification to the FDA pursuant to Section 510(k) of the U.S. Food, Drug and Cosmetic Act for its Yttrium-90 (Y-90) RadioGel(tm) patented brachytherapy cancer product.
The U.S. Army Medical Research and Development Command announced today that the U.S. Food and Drug Administration granted marketing approval for Artesunate for Injection, an initial treatment for severe malaria.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica L Macleod, APRN Po Box 547, Att: Cvmc Finance Dept, Barre, VT 05641-0547 Ph: (802) 371-4700 | Jessica L Macleod, APRN 142 Woodridge Drive, Berlin, VT 05602-9516 Ph: (802) 371-4700 |
News Archive
Great Lakes NeuroTechnologies announced today they will be using a $1.5M award from NIH to expand their Parkinson's monitoring technology to mobile applications. Repositioning GLNT's Kinesia product line with mobile apps strategically aligns with growing trends in domestic and international healthcare landscapes regarding accessibility, costs, reimbursement, and regulatory policies.
A recent study found that living donation increased 42% and the number of individuals who presented for donation evaluation increased 74% at centers in New York. The surge in live donation and donor evaluation occurred after additional education was provided to liver transplant candidates.
Advanced Medical Isotope Corporation ("AMIC"), a company engaged in the development, production and distribution of medical isotopes focused on yttrium-90 brachytherapy devices, today announced that it has received a response from the FDA to its pre-market notification to the FDA pursuant to Section 510(k) of the U.S. Food, Drug and Cosmetic Act for its Yttrium-90 (Y-90) RadioGel(tm) patented brachytherapy cancer product.
The U.S. Army Medical Research and Development Command announced today that the U.S. Food and Drug Administration granted marketing approval for Artesunate for Injection, an initial treatment for severe malaria.
› Verified 7 days ago
Ms. Quincy Campbell, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1311 Barre-montpelier Rd, Berlin, VT 05602 Phone: 802-371-4239 Fax: 802-371-4237 | |
Christina Marie Tourangeau, APRN, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1311 Barre-montpelier Road, Suite 200, Berlin, VT 05602 Phone: 802-371-4239 Fax: 802-371-4237 | |
David Alexander Segel, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Berlin, VT 05602 Phone: 802-225-7000 | |
Karen Gibbs, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 142 Woodridge Rd, Berlin, VT 05602 Phone: 802-371-4700 | |
Abbey Lynne Rouleau, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: Cvmc Palliative Care, 130 Fisher Road 2nd Floor, Berlin, VT 05602 Phone: 802-371-5372 | |
Margaret Jones, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 130 Fisher Rd, Berlin, VT 05602 Phone: 802-471-2100 | |
Morgan Lamson, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: Central Vermont Medical Center, 130 Fisher Road, Berlin, VT 05602 Phone: 802-371-4700 Fax: 802-371-4720 |